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Spatiotemporal proﬁ ling of luteinising hormone/human 
choriogonadotropin receptor in the human fetal testis
Joni Macdonald*, Lee B Smith*, Richard A Anderson, Rod T Mitchell 
Abstract 
Background Androgen signalling is essential for masculinisation of the male fetus. Failure of masculinisation during 
fetal life can result in disorders of sex development. Masculinisation is mediated partly by ligand binding to the 
luteinising hormone/human choriogonadotropin receptor (LHCGR). In rodents, the initial stages of masculinisation 
are gonadotropin independent, though whether this also occurs in human beings remains unknown because accurate 
timing and cell-type localisation of LHCGR protein expression in human fetal testis remains unresolved. We aimed 
to characterise the spatiotemportal expression of LHCGR in human fetal testis.
Methods Human fetal testis tissue (n=12, 8–20 weeks’ gestation) was obtained from elective terminations after 
informed patient consent. We used a combination of RT-PCR for LHGCR and Leydig cells (marker 3β hydroxysteroid 
dehydrogenase [3βHSD]) and immunoﬂ uorescent co-localisation for LHCGR, Leydig cell steroidogenesis (3βHSD), 
and endothelial cells (markers CD31 and von Willebrand factor) to determine the exact timing and cellular location 
of LHCGR mRNA and protein in the human fetal testis. The study received ethics approval.
Findings LHCGR mRNA was detected from 9 weeks’ gestation, but protein was not detectable until 12 weeks’. 
Expression of 3βHSD (indicating active steroidogenesis) was detected in the ﬁ rst trimester (10 weeks’) preceding the 
expression of LHCGR. LHCGR did not co-localise with the Leydig cell marker 3βHSD during the early second trimester 
and only became consistently co-localised at 20 weeks’ gestation. Before expression in fetal Leydig cells, LHCGR was 
restricted to endothelial cells (demonstrated by co-localisation with CD31 and von Willebrand factor).
Interpretation These results indicate that gonadotropin-mediated signalling through the LHCGR in human fetal 
Leydig cells is not established until later than previously described, suggesting a period of gonadotropin insensitivity 
during masculinisation in fetal life. Future functional studies will determine the mechanisms involved in androgen 
signalling in the human fetal testis. The present ﬁ ndings are important for understanding the pathogenesis 
of disorders of sex development in man.
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